Market Overview

Navidea to Present Data from Lymphoseek Studies at RSNA, CTRC-AACR Meetings

Share:
Related NAVB
12 Biggest Mid-Day Gainers For Friday
Mid-Day Market Update: Crude Oil Down 3.5%; Navidea Shares Spike Higher

Navidea Biopharmaceuticals, Inc. (NYSE: NAVB) today announced that data from its Lymphoseek^® (technetium Tc 99m tilmanocept) studies in breast cancer and melanoma are being presented during the Radiological Society of North America Conference (RSNA) in Chicago and the CTRC-AACR San Antonio Breast Cancer Symposium in San Antonio, Texas.

Posted-In: News

 

Related Articles (NAVB)

View Comments and Join the Discussion!